跳至主要内容
临床试验/NCT01505361
NCT01505361Unknown1 期

Oral Administration of a Probiotic Strain to Pregnant Women: Effects on the Prevention of Lactational Mastitis and on the Eradication of GBS Colonization

Universidad Complutense de Madrid2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2011年11月最近更新:
适应症
干预措施

试验速览

阶段
1 期
入组人数
100
试验地点
2
主要终点
Evidence of clinical mastitis confirmed by microbiological cultures and somatic cell counts

研究概览

简要总结

In previous studies, the investigators have seen that carefully-selected Lactobacillus strains are a good alternative to antibiotics for the treatment of lactational mastitis. The objective of this new study is to check if they can also have a preventive role when administered to women with a history of mastitis with one or more previous infants. Since the investigators have also realized that peripartum antibiotherapy (mainly GBS-targeting intrapartum prophylaxis)is a predisposing factor for mastitis (because of the selection of resistant bacteria), the investigators would also like to test if administration of the strains to GBS-colonized pregnant women may lead to GBS eradication. Therefore, a mastitis-predisposing factor would de avoid.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
25 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Normal pregnancy
  • Healthy women
  • Lactational mastitis in, at least, a previous lactation period
  • No symptomatic vaginal infections

排除标准

  • Any kind of health problems related to pregnancy
  • Symptomatic vaginal infections
  • Allergy to cow's milk protein
  • Intolerance to lactose
  • Antibiotic treatment

研究组 & 干预措施

Probiotic

Experimental

Pregnant women at 30 week of pregnancy(n=50) receiving Lactobacillus salivarius PS2(9 log per day, until birth)

干预措施: Lactobacillus salivarius PS2 (Biological)

Placebo

Placebo Comparator

Pregnant women at 30 week of pregnancy(n=50) receiving the excipient (once a day, until birth)

干预措施: Excipient (milk powder) (Biological)

结局指标

主要结局

Evidence of clinical mastitis confirmed by microbiological cultures and somatic cell counts

时间窗: Weekly during the first 6 months after birth

次要结局

  • Evidence of eradication og GBS colonization as confirmed by microbiological analysis of vaginal exudate and rectal swab(At weeks 30, 35, 40 of pregnancy)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Juan M. Rodríguez

Professor, PhD

Universidad Complutense de Madrid

研究点 (2)

Loading locations...

相似试验

Study of a Probiotic Strain to Prevent Mastitis and... | 临床试验